Highlights
NASDAQ: BGNE       Beigene Ltd ADR
Last Price Today's Change   Day's Range   Trading Volume
174.84   -2.99 (1.68%)  171.75 - 175.99  100,445

Overview

 
Avg Volume (4 weeks):198,644
4 Weeks Range:161.08 - 199.60
4 Weeks Price Volatility (%):
35.72%
52 Weeks Range:118.18 - 426.56
52 Weeks Price Volatility (%):
18.37%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2594  7163  1126  1344 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ENDP 0.40-0.006 
 BBBY 11.03-7.52 
 VLCN 2.42+0.58 
 TQQQ 35.35-2.20 
 SQQQ 36.66+2.02 
 MNMD 0.847-0.173 
 UVXY 9.37+0.62 
 OXY 71.29+6.41 
 AGLE 0.91+0.405 
 MULN 0.754-0.052